For 2015 the consensus of the earnings per share of Merck KGaA is at profit of 4,88 euros. Based on this the price/earnings-ratio equals 16,32.
The consensus of the dividends per share is at 1,08 euros.Consequently the dividend return is around 1,36 percent. On average the stocks in this sector yield a dividend return of around 0,52 percent.
The stocks Mithra, Kiadis and Roche in the sector pharmaceutical sector have the most buy recommendations. The 3 most recent recommendations for the pharmaceutical sector were provided by Equinet-ag (hold, 96,00 euros), Deutsche Bank (buy, 88,00 euros) and Commerzbank (buy, 95,00 euros).
Merck KGaA's book value/price equals 0,23. The pharmaceutical company now trades at a Shiller PE of 23.58. The stock now trades at 79,64 euros. This equals 60 times the 2014's earnings per share.